Navigation Links
Leading Dental Stem Cell and Regenerative Medicine Researcher Dr. George Huang Joins StemSave's Science Advisory Council
Date:1/18/2011

NEW YORK, Jan. 18, 2011 /PRNewswire/ -- StemSave, the market leader in the field of dental stem cell recovery and cryo-preservation, today announced Dr. George T.-J. Huang, DDS, MSD, DSc, the Chair and Herbert Schilder Professor in Endodontics and Director of the Postgraduate Program in Endodontics of Boston University's Henry M. Goldman School of Dental Medicine, joined its Science Advisory Council.  Dr. Huang will support and advise StemSave as it continues to expand its easy-to-use stem cell banking technology that lets people store stem cells collected from their own teeth as part of a routine visit to the dentist's office.

"Dr. Huang is a preeminent member of the dental stem cell research community and his work around tissue regeneration is changing the way we think about dentistry.  His expertise will play a critical role in our continued growth and we are very fortunate to have him on board," says Art Greco, CEO of StemSave.

Dr. Huang has published more than 100 research articles, review articles, book chapters and abstracts on stem cell development and regenerative medicine.  His research focuses on using dental stem cells to advance regenerative medicine, in particular the use of dental stem cells to create iPS cell lines as well as the regeneration of dental tissues such as dental pulp, dentin and periodontal ligament.

"Stem cell based tissue regeneration is going to play an increasingly more vital role in the medical health and treatments of people today.  StemSave understands that to take full advantage of these medical breakthroughs, people need an easy way to bank their stem cells at any time in life – and it doesn't get easier than a routine trip to the dentist's office," says Dr. Huang.  

Dr. Huang joins Dr. Jeremy J. Mao, DDS, PhD; Gordana Vunjak-Novakovic, PhD; and David A Matzilevich, MD, PhD on the StemSave advisory council.

StemSave, Inc.

StemSave provides an affordable and non-invasive method for the recovery and cryo-preservation of the powerful Adult Stem Cells found in teeth by teaming up with dentists to harvest stem cells during routine dental procedures. For more information, visit www.StemSave.com.


'/>"/>
SOURCE StemSave, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Canopus Biopharma and Leading Chinese Researcher Team Up to Treat Avian Influenza, to Prevent Possible Pandemic
2. Leading Biopharmas Will Deliver Case Studies on Achieving Productivity Excellence through Engagement, Technology, Other Tools
3. Brain Cancer Patients at Two Leading Hospitals Treated Using Fast and Efficient RapidArc Radiotherapy Technology from Varian Medical Systems
4. Arius announces leading independent proxy firm, RiskMetrics ISS Canada, recommends shareholders vote for the arrangement involving its acquisition by Roche
5. Trusted LASIK Surgeons Welcomes Leading LASIK Eye Surgery Expert, Inventor David Huang, M.D., Los Angeles, to Its Unique Lasik Directory Service
6. ThalesNano, Inc. Forms Collaborations with Leading US Universities based on the Award Winning H-Cube(R) and H-Cube Midi(TM)
7. CORD:USE Cord Blood Bank is Proud to Announce that Cord Blood Pioneer and Leading Transplanter Dr. Eliane Gluckman has Joined its Team
8. Dynamic Signs Asset Acquisition Deal With Cannex and Brings Onboard Leading Medical Cannabis Research Scientist Dr. Robert Melamede, Former Chairman of the Biology Department, University of Colorado
9. Leading Heart Specialist Joins Duska Therapeutics as Scientific Consultant
10. Patent Technologies Keep CGMT in a Leading Position in the Industry
11. MGuard(TM), InspireMDs Novel Coronary Stent System, was Celebrated by World Leading Interventional Cardiologists at the Transcatheter Cardiovascular Therapeutics (TCT) in Washington DC, USA, October 12-17 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
(Date:6/23/2016)... SPRING, Md. , June 23, 2016 A ... collected from the crime scene to track the criminal down. ... and the U.S. Food and Drug Administration (FDA) uses DNA ... Sound far-fetched? It,s not. The ... genome sequencing to support investigations of foodborne illnesses. Put as ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... YM (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. ... microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory and ...
(Date:6/23/2016)... 23, 2016  The Biodesign Challenge (BDC), a university ... to harness living systems and biotechnology, announced its winning ... New York City . ... showcased projects at MoMA,s Celeste Bartos Theater during the ... MoMA,s senior curator of architecture and design, and ...
Breaking Biology Technology:
(Date:4/26/2016)... , April 27, 2016 ... "Global Multi-modal Biometrics Market 2016-2020"  report to their ... , The analysts forecast the global ... of 15.49% during the period 2016-2020.  ... of sectors such as the healthcare, BFSI, transportation, ...
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
(Date:4/14/2016)... TEL AVIV, Israel , April 14, 2016 /PRNewswire/ ... in Behavioral Authentication and Malware Detection, today announced the ... has already assumed the new role. Goldwerger,s ... for BioCatch, on the heels of the deployment of ... In addition, BioCatch,s behavioral biometric technology, which discerns unique ...
Breaking Biology News(10 mins):